KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Oscar Health (OSCR) Cost of Revenue (2020 - 2025)

Oscar Health (OSCR) has disclosed Cost of Revenue for 6 consecutive years, with $2.6 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cost of Revenue rose 26.87% year-over-year to $2.6 billion, compared with a TTM value of $10.0 billion through Dec 2025, up 36.64%, and an annual FY2025 reading of $10.0 billion, up 36.64% over the prior year.
  • Cost of Revenue was $2.6 billion for Q4 2025 at Oscar Health, up from $2.6 billion in the prior quarter.
  • Across five years, Cost of Revenue topped out at $2.6 billion in Q4 2025 and bottomed at $268.0 million in Q1 2021.
  • Average Cost of Revenue over 5 years is $1.3 billion, with a median of $1.2 billion recorded in 2023.
  • The sharpest move saw Cost of Revenue skyrocketed 656.38% in 2021, then increased 26.87% in 2025.
  • Year by year, Cost of Revenue stood at $482.5 million in 2021, then skyrocketed by 83.4% to $884.9 million in 2022, then surged by 36.2% to $1.2 billion in 2023, then surged by 71.34% to $2.1 billion in 2024, then increased by 26.87% to $2.6 billion in 2025.
  • Business Quant data shows Cost of Revenue for OSCR at $2.6 billion in Q4 2025, $2.6 billion in Q3 2025, and $2.6 billion in Q2 2025.